A New Drug Aimed at Midlife Depression in Women
SheSez with Linda Grasso
English - June 01, 2022 00:58 - 34 minutes - 47.3 MB - ★★★★★ - 149 ratingsPersonal Journals Society & Culture Business Careers motherhood antiaging careerpivot careers emptynest femaleentrepreneurs femaleleaders forwardthinkers happiness health Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Why Illustrator Alessandra Olanow Captures Our Hearts & Minds
Two NIH researchers—Dr. Sarah A. Rudzinskas and Sarah Spector—on studies they are helping conduct for a new drug aimed at helping women in midlife who suffer from depression-typically for the first time in their lives.
An estimated 20% of American women have depression at some point during menopause; and 38% experience depression in late menopause. The researchers are exploring the link between low levels of estrogen and how it impacts the brain—which this new drug, manufactured by the pharmaceutical company Eli Lily, addresses.
Women interested in being part of the NIH study can click here for more information.